<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Carysil Ltd. (CARYSIL) — Tipsheet</title>
    <link>https://tipsheet.markets/company/carysil/</link>
    <atom:link href="https://tipsheet.markets/company/carysil/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Carysil Ltd. (CARYSIL), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Mon, 06 Jul 2026 10:22:47 GMT</lastBuildDate>
    <item>
      <title>Carysil&#39;s Q4 transcript offers no surprises</title>
      <link>https://tipsheet.markets/carysil-carysil-s-q4-transcript-offers-no-surprises-100011/</link>
      <guid isPermaLink="true">https://tipsheet.markets/carysil-carysil-s-q4-transcript-offers-no-surprises-100011/</guid>
      <pubDate>Wed, 27 May 2026 14:48:58 GMT</pubDate>
      <description>The latest earnings call transcript confirms existing guidance and expansion plans, adding no new material information.</description>
      <content:encoded><![CDATA[<p><em>The latest earnings call transcript confirms existing guidance and expansion plans, adding no new material information.</em></p>
<h3>What’s new</h3><ul><li>The Q4 FY2026 earnings call transcript contains no new material developments.</li><li>Management reaffirmed revenue growth targets of 15-20%.</li><li>EBITDA margin guidance remains set at 18-20%.</li></ul>
<h3>Why it matters</h3><p>The transcript is a routine record of previously disclosed financial results and strategic plans. Investors looking for incremental updates on capacity expansion or margin shifts will find nothing new here.</p>
<h3>What we’re watching</h3><ul><li>Actual execution of capacity expansion timelines.</li><li>Whether margins hold within the 18-20% target range.</li><li>Any deviation from the 15-20% revenue growth path.</li></ul>
<h3>The full read</h3><p>Carysil's Q4 FY2026 earnings call transcript provides a detailed review of the company's performance, but it breaks no new ground. Management used the call to reiterate existing guidance, specifically targeting <strong>15-20%</strong> revenue growth and <strong>18-20%</strong> EBITDA margins. The transcript also confirms that capacity expansion timelines remain unchanged from previous disclosures.</p>
<p>No surprises here.</p>
<p>This filing is a standard record of the quarter rather than a source of fresh insight, confirming that the company is sticking to its previously communicated strategy while maintaining a steady operational pace despite the lack of new information for the market to digest.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=524091&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=CARYSIL">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Carysil&#39;s capacity expansion timelines pushed back by 9-12 months</title>
      <link>https://tipsheet.markets/carysil-carysil-s-capacity-expansion-timelines-pushed-back-by-9-12-months-94331/</link>
      <guid isPermaLink="true">https://tipsheet.markets/carysil-carysil-s-capacity-expansion-timelines-pushed-back-by-9-12-months-94331/</guid>
      <pubDate>Thu, 21 May 2026 17:09:36 GMT</pubDate>
      <description>In a concall, management confirmed delays of 9-12 months on quartz sink and appliances capacity, while reaffirming revenue and margin guidance.</description>
      <content:encoded><![CDATA[<p><em>In a concall, management confirmed delays of 9-12 months on quartz sink and appliances capacity, while reaffirming revenue and margin guidance.</em></p>
<h3>What’s new</h3><ul><li>Quartz sink capacity expansion delayed from April 2026 to Q4 FY27.</li><li>Appliances capacity expansion pushed from Q2 FY27 to FY28.</li><li>Revenue and margin guidance for FY27 reaffirmed despite delays.</li></ul>
<h3>Why it matters</h3><p>Capacity delays of this magnitude signal execution challenges that could weigh on near-term growth. However, reaffirmed guidance suggests existing capacity is sufficient for current demand, limiting the downside risk. The question is whether these delays compound into further slippage.</p>
<h3>What we’re watching</h3><ul><li>Whether new capacity starts on time in Q4 FY27.</li><li>Any impact on FY27 revenue if demand outpaces installed capacity.</li><li>Management's communication on root cause of delays.</li></ul>
<h3>The full read</h3><p>Carysil has revised its capacity expansion schedule, with quartz sink capacity now expected in Q4 FY27 versus April 2026 earlier, and appliances capacity slipping from Q2 FY27 to FY28. The concall management attributed the delays to equipment delivery and installation challenges, but reaffirmed FY27 revenue and margin guidance. This suggests that while near-term growth isn't materially impacted, the delayed capacities are needed for future growth. Investors should watch for any further delays or changes in demand that could strain capacity utilization.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=524091&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=CARYSIL">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>